Dupilumab for the treatment of refractory lenalidomide rash in patients with multiple myeloma

被引：3
|
作者：
Kuo, Alyce M. [1 ]
Hassoun, Hani [2 ]
Shah, Urvi [2 ]
Gordon, Allison [1 ]
Hollmann, Travis J. [3 ]
Landau, Heather J. [4 ]
Lezcano, Cecilia [3 ]
Mailankody, Sham [2 ]
Tan, Carlyn C. [2 ]
Lesokhin, Alexander M. [2 ]
Markova, Alina [1 ]
机构：
[1] Mem Sloan Kettering Canc Ctr, Dept Med, Dermatol Serv, 545 E 73rd St, New York, NY 10021 USA
[2] Mem Sloan Kettering Canc Ctr, Dept Med, Myeloma Serv, New York, NY USA
[3] Mem Sloan Kettering Canc Ctr, Dept Pathol, Dermatopathol Serv, New York, NY USA
[4] Mem Sloan Kettering Canc Ctr, Dept Med, Adult Bone Marrow Transplant Serv, New York, NY USA
来源：
LEUKEMIA & LYMPHOMA | 2022年 / 63卷 / 09期
关键词：
CELLS; SKIN;
D O I：
10.1080/10428194.2022.2068002
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：2233 / 2237
页数：5
相关论文
共 50 条
  • [1] Lenalidomide for the treatment of relapsed or refractory multiple myeloma
    Weber, D. M.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 (06): : 22 - 24
  • [2] Prolonged treatment with lenalidomide in relapsed and refractory multiple myeloma
    Franco C.A.
    Palomera L.
    Arredondo J.J.R.
    Sánchez J.M.
    Advances in Therapy, 2011, 28 (Suppl 8) : 14 - 19
  • [3] LENALIDOMIDE THERAPY IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA
    Okada, K.
    Okamoto, Y.
    Tsukamoto, T.
    Sugiura, H.
    Matsui, H.
    Ueda, T.
    Jo, T.
    Onishi, T.
    Kunitomi, A.
    Ueda, Y.
    ANNALS OF ONCOLOGY, 2013, 24
  • [4] Lenalidomide plus dexamethasone treatment in Japanese patients with relapsed/refractory multiple myeloma
    Shinsuke Iida
    Takaaki Chou
    Shinichiro Okamoto
    Hirokazu Nagai
    Kiyohiko Hatake
    Hirokazu Murakami
    Toshiyuki Takagi
    Kazuyuki Shimizu
    Henry Lau
    Kenichi Takeshita
    Masaaki Takatoku
    Tomomitsu Hotta
    International Journal of Hematology, 2010, 92 : 118 - 126
  • [5] Lenalidomide plus dexamethasone treatment in Japanese patients with relapsed/refractory multiple myeloma
    Iida, Shinsuke
    Chou, Takaaki
    Okamoto, Shinichiro
    Nagai, Hirokazu
    Hatake, Kiyohiko
    Murakami, Hirokazu
    Takagi, Toshiyuki
    Shimizu, Kazuyuki
    Lau, Henry
    Takeshita, Kenichi
    Takatoku, Masaaki
    Hotta, Tomomitsu
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2010, 92 (01) : 118 - 126
  • [6] Outcomes and management of lenalidomide-associated rash in patients with multiple myeloma
    Barley, Kevin
    He, Wei
    Agarwal, Shradha
    Jagannath, Sundar
    Chari, Ajai
    LEUKEMIA & LYMPHOMA, 2016, 57 (11) : 2510 - 2515
  • [7] Lenalidomide in combination with dexamethasone for the treatment of relapsed or refractory multiple myeloma
    Palumbo, Antonio
    Dimopoulos, Meletios
    San Miguel, Jesus
    Harousseau, Jean-Luc
    Attal, Michel
    Hussein, Mohamad
    Knop, Stefan
    Ludwig, Heinz
    von Lilienfeld-Toal, Marie
    Sonneveld, Pieter
    BLOOD REVIEWS, 2009, 23 (02) : 87 - 93
  • [8] EXPERIENCE IN THE USE OF LENALIDOMIDE FOR THE TREATMENT OF RELAPSE/REFRACTORY MULTIPLE MYELOMA
    Escobar Cristian, Escolano
    de Marcos Nieves, Somolinos
    Compan Francis, Ona
    Parra Laurentino, Benito
    Zabala Itziar, Carmona
    Gullon Esther, Chica
    Alonso Luis, Garcia
    Monteserin Carmen, Monteserin
    Esteban Teresa, Palomo
    Esteban Casimira, Teno
    Bermejo Ana, Yeguas
    Miguel Angel, Alvarez Juarez
    HAEMATOLOGICA, 2016, 101 : 103 - 103
  • [9] Developing a prediction model for response to lenalidomide treatment in refractory/relapsed multiple myeloma patients
    Chung, Y-J.
    Yim, S-H.
    Jung, S-H.
    ANNALS OF ONCOLOGY, 2017, 28
  • [10] Treatment of relapsed/refractory multiple myeloma patients with lenalidomide/dexamethasone in routine clinical practice
    Schwarzer, A.
    Fruehauf, S.
    Knigsmann, M.
    Schnell, R.
    Reeb, M.
    Heits, F.
    Tirier, C.
    Prange-Krex, G.
    Knauf, W.
    Bachinger, A.
    Weiligmann, C.
    Hoppe, G.
    Glasmacher, A.
    Schmidt, B.
    ONCOLOGY RESEARCH AND TREATMENT, 2014, 37 : 291 - 291
12345